Mehta, P., Thummar, V., & Bhavsar, H. (2026). Clinical outcomes of neoadjuvant dual HER2 blockade with pertuzumab/Sigrima and trastuzumab/Vivitra biosimilars: real-world evidence in HER2-positive breast cancer in India. International Journal of Research in Medical Sciences, 14(4), 1584–1588. https://doi.org/10.18203/2320-6012.ijrms20260973